Clinical Trial Update: Pilot Study of Ranibizumab With and Without Ketorolac Eyedrops for Exudative Age-related Macular Degeneration [Phase 4]

View source ↗

Summary

This Phase 4 pilot trial compares ranibizumab with and without ketorolac eye drops for exudative age-related macular degeneration. The study status is completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• Ketorolac ophthalmic solution (Ketorolac)
• Ranibizumab (ranibizumab)

Snippet

Sponsor: Università degli Studi di Brescia | Conditions: Wet Macular Degeneration | Phase 4 | Status: COMPLETED